ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property
SpineThera SALIENT Clinical Trial Results to Be Presented at Upcoming 22nd Annual ASRA Pain Medicine Meeting
SpineThera Announces Breakthrough Market Research Results for SX600 in the Management of Sciatica Pain
SpineThera Announces Results for SX600 from its SALIENT Phase 2 Sciatica Pain Clinical Trial Supporting the Potential for Best-In-Class Therapy